Dr Agarwal’s Healthcare IPO is now open for subscription, with a price range of Rs 382-402 per share. Despite a significant OFS component and rich pricing, analysts recommend investing for the long term. The company commands a 25% market share in India’s eye care service market, benefiting from industry growth projections.
Kaynes shares plunge 43% from October peak. Is a tactical rebound on the cards or more pain ahead?
Kaynes has plunged 43.5% from its October peak, with Friday’s 12.5% drop marking the steepest single-day decline. Momentum indicators remain bearish, signaling a risk of